The next focusIR Investor Webinar takes place tomorrow with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksShearwater Regulatory News (SWG)

Share Price Information for Shearwater (SWG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 46.50
Bid: 45.00
Ask: 48.00
Change: 2.50 (5.68%)
Spread: 3.00 (6.667%)
Open: 44.00
High: 46.50
Low: 44.00
Prev. Close: 44.00
SWG Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Update on acquisition of Xcina Consulting

31 May 2018 07:00

RNS Number : 7596P
Shearwater Group PLC
31 May 2018
 

 

31 May 2018

 

SHEARWATER GROUP PLC

("Shearwater", the "Company" or the "Group")

 

Update on acquisition of Xcina Consulting

 

Shearwater Group plc (AIM: SWG), the digital resilience group, is pleased to announce that its portfolio company, Xcina Consulting, has won in excess of 30 new customers since the Group acquired the business in July 2017 (the "Acquisition"), which have already generated £1 million in incremental revenues for the business.

 

Prior to Acquisition, Xcina Consulting (formerly Newable Consulting) was generating £2.4 million of revenue and was loss making at the EBITDA level. The attraction for the Group was the quality of the incoming team and the opportunity to scale the business.

 

Following the addition of these new client contract wins to existing revenues, the Company is delighted to report that the business is now trading profitability on a reported basis at the EBITDA level and is ahead of the Board's expectations.

 

As a result of this growth, the business is also at the same time, pleased to announce that it has opened its first international office in the US, which will enable the Xcina Consulting team to better serve its current and prospective multinational clients.

 

Michael (Mo) Stevens, Group Chief Executive Officer of Shearwater, said: "We are thrilled with the substantial progress Xcina Consulting has made since joining the Group. Delivering £1 million worth of new business and becoming profitable in less than a year is a tremendous achievement for Mark and the team, and we are delighted the benefits of accessing the wider Shearwater Group infrastructure are being realised so early on."

 

Mark Child, Executive Managing Director of Xcina Consulting, added: "The market for business and technology risk assurance and advisory services is rapidly evolving and we are really excited about the expansion of our capability beyond traditional GRC services which is enabling us to meet the digital, operational and regulatory resilience requirements of our growing client base."

 

 

Enquiries:

 

Shearwater Group plc

David Williams

Michael (Mo) Stevens

 

www.theshearwatergroup.co.uk

+44 (0) 797 014 8016

+44 (0) 780 171 2582

Cenkos Securities plc - NOMAD and Broker

Max Hartley - NOMAD

Julian Morse / Michael Johnson - Sales

+44 (0) 20 7397 8900

Powerscourt - Financial PR

Ben Griffiths, Andy Jones

shearwater@powerscourt-group.com

+44 (0) 20 7250 1446

+44 (0) 77 5346 4637

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
FURFKKDNCBKDBPN
Date   Source Headline
3rd Apr 20247:00 amRNSFY24 Trading Update
4th Jan 20247:00 amRNSContract Wins
22nd Nov 20237:00 amRNSInterim Results
21st Nov 202311:18 amRNSChange of Nominated Adviser and Broker
20th Nov 20231:19 pmRNSBoard Update
3rd Nov 202310:12 amRNSNotice of Results and Board Appointment
10th Oct 20237:00 amRNSInterim CFO Appointment
5th Sep 20237:00 amRNSFinal Results
25th Aug 20237:00 amRNSUpdate re FY23 Results and Trading Update
8th Jun 20237:00 amRNSTrading Update
5th May 20232:33 pmRNSHolding(s) in Company
18th Apr 20238:58 amRNSDirector/PDMR Shareholding
17th Apr 202312:51 pmRNSDirector/PDMR Shareholding
6th Apr 20237:00 amRNSDirector/PDMR Shareholding
31st Mar 20232:05 pmRNSSecond Price Monitoring Extn
31st Mar 20232:00 pmRNSPrice Monitoring Extension
31st Mar 20239:05 amRNSSecond Price Monitoring Extn
31st Mar 20239:00 amRNSPrice Monitoring Extension
31st Mar 20237:00 amRNSTrading Update
8th Mar 20233:30 pmRNSHolding(s) in Company
28th Feb 20231:26 pmRNSExercise of Options
8th Dec 20222:34 pmRNSDirector/PDMR Shareholding
6th Dec 20227:00 amRNSDirector/PDMR Shareholding
1st Dec 20222:40 pmRNSDirector/PDMR Shareholding
29th Nov 20222:05 pmRNSSecond Price Monitoring Extn
29th Nov 20222:00 pmRNSPrice Monitoring Extension
29th Nov 20227:00 amRNSResults for the six months ended 30 September 2022
23rd Nov 20227:00 amRNSAdviser Update
17th Nov 20227:00 amRNSNotice of Results and Presentation to Investors
7th Oct 20228:32 amRNSHolding(s) in Company
5th Oct 20227:00 amRNSDirector/PDMR Shareholding
21st Sep 20227:00 amRNSResult of AGM
5th Sep 202210:00 amRNSNotice of AGM
1st Sep 20227:00 amRNSContract Renewal
25th Aug 20227:00 amRNSPosting of Annual Report
23rd Aug 20222:43 pmRNSDirector/PDMR Shareholding
29th Jul 20227:00 amRNSFinal Results
22nd Jul 20227:00 amRNSNotice of Results and Presentation to Investors
6th Jun 20224:41 pmRNSSecond Price Monitoring Extn
6th Jun 20224:36 pmRNSPrice Monitoring Extension
27th Apr 20227:00 amRNSYear End Trading Update
13th Apr 20227:00 amRNSContract Win
24th Mar 20227:00 amRNSContract Win
22nd Mar 20224:37 pmRNSExercise of options
17th Mar 20227:00 amRNSContract Win
3rd Mar 20224:26 pmRNSHolding(s) in Company
11th Feb 20227:00 amRNSGrant of Options and Director/PDMR Dealing
27th Jan 20227:00 amRNSContract Renewals
11th Jan 20227:00 amRNSContract Win
14th Dec 20217:00 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.